Difference between revisions of "Pentraxin 2 (PRM-151)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
|||
| Line 8: | Line 8: | ||
===[[Myelofibrosis]]=== | ===[[Myelofibrosis]]=== | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Myelofibrosis medications]] | [[Category:Myelofibrosis medications]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
Revision as of 23:26, 13 June 2018
General information
Class/mechanism per NCI Drug Dictionary: A fully recombinant form of the human pentraxin 2 (PTX2) protein with potential antifibrotic activity. Upon intravenous administration, recombinant human serum amyloid P/pentraxin 2 (PRM-151) may inhibit myofibroblast generation by preventing the differentiation of circulating monocytes into fibrocytes and profibrotic macrophages. PTX2 is a circulating plasma protein that belongs to the class of pattern recognition receptors (PRR) of the innate immune system.
Route: IV
Extravasation: n/a